Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Human Vaccines & Immunotherapeutics
Volume 19, 2023 - Issue 3
Immunotherapy - Cancer
Autologous engineered T cell receptor therapy in advanced cancer
Apostolia M. Tsimberidoua Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0003-2713-233XView further author information
https://orcid.org/0000-0003-2713-233XView further author information, Mehmet A. Baysala Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0002-8446-6531View further author information
https://orcid.org/0000-0002-8446-6531View further author information, Abhijit Chakrabortya Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0002-3822-5657View further author information
https://orcid.org/0000-0002-3822-5657View further author information & Borje S. Anderssonb Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0003-4761-0220View further author information
https://orcid.org/0000-0003-4761-0220View further author information